NFKB1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Because of this positive cross-linking and regulatory loop, we next examined the effect of specific inhibition of constitutive NF-κB activation in PaCa cells, using a specific NF-κB activation inhibitor, JSH-23.